125 related articles for article (PubMed ID: 33667584)
1. Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning.
Kouwenberg J; Penninkhof J; Habraken S; Zindler J; Hoogeman M; Heijmen B
Radiother Oncol; 2021 May; 158():224-229. PubMed ID: 33667584
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
3. Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
Tambas M; van der Laan HP; Rutgers W; van den Hoek JGM; Oldehinkel E; Meijer TWH; van der Schaaf A; Scandurra D; Free J; Both S; Steenbakkers RJHM; Langendijk JA
Radiother Oncol; 2021 Jul; 160():61-68. PubMed ID: 33892024
[TBL] [Abstract][Full Text] [Related]
4. SISS-MCO: large scale sparsity-induced spot selection for fast and fully-automated robust multi-criteria optimisation of proton plans.
Kong W; Oud M; Habraken SJM; Huiskes M; Astreinidou E; Rasch CRN; Heijmen BJM; Breedveld S
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38224619
[No Abstract] [Full Text] [Related]
5. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
6. Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.
Ribeiro CO; Visser S; Korevaar EW; Sijtsema NM; Anakotta RM; Dieters M; Both S; Langendijk JA; Wijsman R; Muijs CT; Meijers A; Knopf A
Radiother Oncol; 2021 Apr; 157():210-218. PubMed ID: 33545257
[TBL] [Abstract][Full Text] [Related]
7. IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis.
Padannayil NM; Sharma DS; Nangia S; Patro KC; Gaikwad U; Burela N
Radiat Oncol; 2023 Jan; 18(1):11. PubMed ID: 36639667
[TBL] [Abstract][Full Text] [Related]
8. First experience with model-based selection of head and neck cancer patients for proton therapy.
Tambas M; Steenbakkers RJHM; van der Laan HP; Wolters AM; Kierkels RGJ; Scandurra D; Korevaar EW; Oldehinkel E; van Zon-Meijer TWH; Both S; van den Hoek JGM; Langendijk JA
Radiother Oncol; 2020 Oct; 151():206-213. PubMed ID: 32768508
[TBL] [Abstract][Full Text] [Related]
9. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
10. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
11. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
13. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
14. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
17. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
18. An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
Jeans EB; Shiraishi S; Manzar G; Morris LK; Amundson A; McGee LA; Rwigema JC; Neben-Wittich M; Routman DM; Ma DJ; Patel SH; Foote RL; Lester SC
Head Neck; 2022 Feb; 44(2):359-371. PubMed ID: 34859516
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
20. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]